1498706

Parbendazole

United States Pharmacopeia (USP) Reference Standard

• Synonyme(s) : Methyl (5-butyl-1H-benzoimidazol-2-yl)carbamate, Methyl 5(6)-butyl-2-benzimidazolecarbamate
• Formule empirique (notation de Hill) : C₁₃H₁₇N₃O₂
• Numéro CAS: 14255-87-9
• Poids moléculaire : 247.29
• NACRES: NA.24
• PubChem Substance ID: 329750671
• UNSPSC Code: 41116107
• MDL number: MFCD18910864

Propriétés

• grade: pharmaceutical primary standard
• agency: USP
• API family: parbendazole
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• storage temp.: 2-8°C
• SMILES string: CCCCc1ccc2nc(NC(=O)OC)[nH]c2c1
• InChI: 1S/C13H17N3O2/c1-3-4-5-9-6-7-10-11(8-9)15-12(14-10)16-13(17)18-2/h6-8H,3-5H2,1-2H3,(H2,14,15,16,17)
• InChI key: YRWLZFXJFBZBEY-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Parbendazole USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Albendazole Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Informations sur la sécurité

• pictograms: GHS08,GHS07
• signalword: Warning
• hcodes: H302,H361fd
• pcodes: P202 - P264 - P280 - P301 + P312 - P308 + P313 - P405
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Classe de stockage: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable